Preserving Expertise in Vitamin K Antagonists in the Era of Direct Oral Anticoagulants: Avoiding Therapeutic Segregation.

Authors

Céline Everard, Catherine Lambert, Cédric Hermans

Published in

Journal of thrombosis and haemostasis : JTH. Aug 28, 2026. Epub Aug 28, 2026.

Abstract

The rapid uptake of direct oral anticoagulants (DOACs) has sharply reduced the prescribing of vitamin K antagonists (VKAs), giving rise to an underappreciated risk: the progressive loss of the clinical expertise required to manage them. Yet several populations remain dependent on VKAs, including patients with mechanical heart valves, high-risk antiphospholipid syndrome, and advanced renal disease, as well as patients in resource-limited settings. These patients face both the intrinsic complexity of VKA therapy and a healthcare environment in which practical experience with these agents is becoming scarce. Preserving this competence is a matter of patient safety and professional responsibility. We argue for a structured response combining education, the maintenance of specialized anticoagulation clinics, patient empowerment, and anticoagulation stewardship, with artificial intelligence remaining, for now, only a prospect.

PMID:
42665232
Bibliographic data and abstract were imported from PubMed on 29 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.